-- Israel Stocks: Ampal, Delek, D-Pharm, Modiin, Kamada, Tower
-- B y   D a v i d   W a i n e r
-- 2012-05-03T10:26:57Z
-- http://www.bloomberg.com/news/2012-05-03/israel-stocks-ampal-delek-d-pharm-modiin-kamada-tower.html
Israelâ€™s  TA-25 index  rose for a third
time this week, advancing 0.3 percent to 1,162.48 at 12:52 p.m.
in Tel Aviv. The measure was little changed this week.  The following stocks rose or fell today. Symbols are in
parentheses.  Ampal-American Israel (AMPL)  Corp tumbled to the lowest
since April 23, falling 7 percent to 0.70 shekel. The owner of a
12.5 percent stake in East Mediterranean Gas Co. said it filed a
request for arbitration against  Egypt  with other EMG investors
for the breach of the bilateral investment treaty between Egypt
and the U.S.  Delek Real Estate Ltd. (DLKR)   plunged the most since
April 16, declining 9.1 percent to 0.159 shekel. The property
company said the Tel Aviv District Court has approved a
liquidation request by series B25 bondholders. The court
appointed a temporary liquidator to reach a debt agreement.  D-Pharm Ltd. (DPRM)   climbed 1.6 percent to 0.984 shekel.
The biopharmaceutical company received $2.4 million to date from
a Chinese partner for the development of an epilepsy drug.  Modiin-LP (MDINL)   advanced the most since April 5,
adding 4.7 percent to 0.355 shekel. Noble Energy Inc. suspended
drilling operations in the Leviathan offshore field.  Kamada Ltd. (KMDA)   rose for the first time in four days,
gaining 2 percent to 26.51 shekels. The biopharmaceutical
company is in talks with potential partners to help sell an
inhaled version of its AAT medicine in Europe, Chief Executive
Officer David Tsur said in an interview.  Tower Semiconductor Ltd. (TSEM)   advanced 3.2 percent to
3.799 shekels. The maker of customized chips entered a
partnership with Rachip to provide external solutions and
services to assist its customers with computer-aided design,
quality assurance and run-set development.  To contact the reporter on this story:
David Wainer in  Tel Aviv  at 
 dwainer3@bloomberg.net   To contact the editor responsible for this story:
Claudia Maedler at 
 cmaedler@bloomberg.net  